Twist Bioscience Corp Stock
Twist Bioscience Corp Stock
The price for the Twist Bioscience Corp stock decreased slightly today. Compared to yesterday there is a change of -€0.210 (-0.750%).
With 9 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 41 € shows a positive potential of 47.75% compared to the current price of 27.75 € for Twist Bioscience Corp.
Criterium "Revenue growth" is seen as the biggest plus for Twist Bioscience Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | -0.750% | 0.653% | 6.119% | -44.411% | -39.318% | 15.217% | -74.541% |
| Pacira Pharmaceuticals | 0.990% | 2.000% | 13.966% | 14.607% | 10.270% | -53.846% | -58.197% |
| Rockwell Medical Inc. | 0.240% | -0.762% | -1.969% | -58.300% | -58.011% | -14.925% | -92.025% |
| Vericel Corp. | 1.310% | -9.884% | -7.186% | -41.509% | -43.119% | 44.186% | 44.995% |
Comments
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Barclays PLC from $40.00 to $37.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Evercore ISI from $46.00 to $42.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
The comment is under review
